Evidence map›Paper›PMID 29120385›Full record

ArticlePharmacy (Basel, Switzerland)2017

Hospital Audit as a Useful Tool in the Process of Introducing Falsified Medicines Directive (FMD) into Hospital Pharmacy Settings-A Pilot Study.

Urszula Religioni, Damian Swieczkowski, Anna Gawrońska, Anna Kowalczuk, Mariola Drozd, Mikołaj Zerhau, Dariusz Smoliński, Stanisław Radomiński, Natalia Cwalina, David Brindley and 2 more

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The Impact of Hospital Pharmacy Operation on the Quality of Patient Care.International journal of environmental research and public health · 2023
    Article
  4. Falsified Medicines Directive in a Secondary Care Environment-Impact on Supply Chain.International journal of environmental research and public health · 2022
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Urszula ReligioniDepartment of Public Health, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland. urszula.religioni@gmail.com.
Damian SwieczkowskiFirst Department of Cardiology, Medical University in Gdansk, Dębinki 7, 80-952 Gdańsk, Poland. d.swieczkowski@gumed.edu.pl.
Anna GawrońskaInstitute of Logistics and Warehousing, Ewarysta Estkowskiego 6, 61-755 Poznań, Poland. anna.gawronska@ilim.poznan.pl.
Anna KowalczukNational Medicines Institute, Chełmska 30/34, 00-725 Warsaw, Poland. a.kowalczuk@nil.gov.pl.
Mariola DrozdDepartment of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093 Lublin, Poland. marioladrozd@umlub.pl.
Mikołaj ZerhauHospital Pharmacy, Mazowiecki Szpitala Specjalistyczny w Ostrołęce, Al. Jana Pawła II 120 A, 07-410 Ostrołęka, Poland. mikizerh@gmail.com.
Dariusz SmolińskiCommunity Pharmacy, Poland. smolinski.d.a@gmail.com.
Stanisław RadomińskiQuizit Sp. z. o. o., Unit Dose, Sprinterów 2/6, 94-022 Łódź, Poland. s.radominski@quizit.eu.
Natalia CwalinaFirst Department of Cardiology, Medical University in Gdansk, Dębinki 7, 80-952 Gdańsk, Poland. ncwalina@gumed.edu.pl.
David BrindleyDepartment of Paediatrics, University of Oxford, Level 2, Children's Hospital, John Radcliffe, Headington, Oxford OX3 9DU, UK. david.brindley@paediatrics.ox.ac.u.
Miłosz J JaguszewskiFirst Department of Cardiology, Medical University in Gdansk, Dębinki 7, 80-952 Gdańsk, Poland. mjaguszewski@gumed.edu.pl.
Piotr MerksDepartment of Pharmaceutical Technology, Faculty of Pharmacy Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-089 Bydgoszcz, Poland. piotrmerks@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecently, the European Union has introduced the Falsified Medicines Directive (FMD). Additionally, in early 2016, a Delegated Act (DA) related to the FMD was published. The main objective of this study was to evaluate the usefulness of external audits in the context of implementing new regulations provided by the FMD in the secondary care environment.

methodsThe external, in-person workflow audits were performed by an authentication company in three Polish hospital pharmacies. Each audit consisted of a combination of supervision (non-participant observation), secondary data analysis, and expert interviews with the use of an independently designed authorial Diagnostic Questionnaire. The questionnaire included information about hospital drug distribution procedures, data concerning drug usage, IT systems, medication order systems, the processes of medication dispensing, and the preparation and administration of hazardous drugs. Data analysis included a thorough examination of hospital documentation in regard to drug management. All data were subjected to qualitative analysis, with the aim of generating meaningful information through inductive inference.

resultsOnly one dispensing location in the Polish hospitals studied has the potential to be a primary authentication area. In the audited hospitals, an Automated Drug Dispensing System and unit dose were not identified during the study. Hospital wards contained an enclosed place within the department dedicated to drug storage under the direct supervision of senior nursing staff. An electronic order system was not available. In the largest center, unused medications are re-dispensed to different hospital departments, or may be sold to various institutions. Additionally, in one hospital pharmacy, pharmacists prepared parenteral nutrition and chemotherapeutic drugs for patients admitted to the hospital.

conclusionsExternal audits might prove beneficial in the course of introducing new regulations into everyday settings. However, such action should be provided before the final implementation of authentication services. To sum up, FMD can impact several hospital departments.

Indexed as

Falsified Medicines Directivehospital pharmacypatient safetypharmaceutical lawpharmacistpoint of authentication

Identifiers

PMID29120385
PMCPMC5748544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.